A recent analysis investigated the state of metabolic disruption experienced by patients with spinal muscular atrophy (SMA), ...

The Institute for Quality and Efficiency in Health Care (IQWiG) was commissioned by the Federal Joint Committee (G-BA) to ...

Moderna stock crashed Thursday after the Covid vaccine maker slashed its R&D budget by $1.1 billion and cut its 2024 sales outlook.

DBS analyst Mark Kong CFA has maintained their bullish stance on MRNA stock, giving a Buy rating yesterday. Mark Kong CFA has given his Buy ...

In an effort to build its commercial capacity, Moderna on Thursday announced it is lowering research and development spending ...

Milan, Italy, 12 September 2024 – Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, today announces the appointment of ...

Looking ahead to 2026-2028, Moderna will expand its commercial portfolio with first-in-class vaccines and therapeutics to address non-respiratory diseases, including cytomegalovirus, norovirus, ...

The Methylmalonic Acidemia drugs in development market research report provides comprehensive information on the therapeutics under development for Methylmalonic Acidemia, complete with analysis by ...

A biochemical reaction is the transformation of one molecule to a different molecule inside a cell. Biochemical reactions are mediated by enzymes, which are biological catalysts that can alter the ...

Background: Aortic dissection (AD) is a fatal cardiovascular disease for which the key involved genes are largely unknown. Here, we aimed to identify promising AD biomarkers from high-throughput RNA ...